Slone Partners

06/18/2026

The right leadership at the right time doesn’t always look like a full-time hire.

Organizations across life sciences and healthcare turn to fractional executives when they are navigating:

• Rapid growth and market expansion
• Turnarounds or post-acquisition integration
• Interim leadership gaps
• Strategic initiatives that require senior expertise

Our Fractional Talent team connects organizations with leaders who can step in, create momentum, and deliver results quickly.

If you are weighing fractional vs. full-time leadership for your next hire, George Quinn, Partner, Fractional Talent, can help you find the right path forward.

📩 [email protected]

06/16/2026

It’s encouraging to see the rise in life sciences IPO and investment activities after a couple of challenging years for the sector.

Now we may start to see a commensurate increase in leadership positions – both full-time and fractional – as companies scale and move toward their next milestone.

Slone Partners CEO & Managing Partner Leslie Loveless offers her perspectives on the topic in this article.

Read more in PharmaVoice.

The industry is showing favorable economic signs, but biotech companies are still taking a measured approach to hiring leaders.

06/15/2026

People Are Our Science®
www.slonepartners.com

06/11/2026

firms play a pivotal role in building successful companies in healthcare and life sciences.

At Slone Partners, we understand the differentiated requirements of working with firms and their portfolio companies, and serve as a trusted partner to build out their teams as they scale and grow.

We are prepared to work with your firm to secure the talent that will complement your teams and drive your success!

Learn more about our Private Equity expertise: https://www.slonepartners.com/private-equity-recruiting/

06/10/2026

This is very exciting news!

Parabilis Medicines has achieved the biggest Nasdaq debut ever for the biopharma industry! The funding from this IPO will help fast track the company’s development of a new treatment for desmoid tumors and highlights continued investor confidence in innovative science with the potential to transform patient care.

Congratulations to the Parabilis team on this milestone—and to the biotech community on another encouraging sign for the sector's future!

Parabilis Medicines prices a $670M IPO — the biggest biotech Nasdaq debut ever — to fund its experimental desmoid-tumor drug zolucatetide.

06/08/2026

Healthcare delivery is evolving fast. Operational complexity, workforce pressure, regulatory shifts, and patient access challenges continue to reshape leadership needs.

Slone Partners’ Hospitals & Healthcare Delivery Solutions team partners with organizations to identify leaders – both full-time and fractional - who can navigate complexity and drive meaningful impact.

With deep expertise across healthcare operations, we place top talent from the C-suite and physician leaders to critical functional roles.

Connect with Claudine Fasse, Vice President, Executive Search, at [email protected] to learn more.

06/02/2026

This month, we recognize those impacted by Alzheimer’s and other brain disorders—and the continued pursuit of better care, access, and outcomes.

At Slone Partners, we’re proud to support leaders advancing innovation across neuroscience, diagnostics, and therapeutics.

Together, we move progress forward.

06/01/2026

🏳️‍🌈 This , we celebrate the LGBTQ+ community and reaffirm our commitment to inclusive workplaces where everyone feels seen, respected, and empowered to thrive. +

05/29/2026

Venture-backed life sciences companies move fast—your leadership strategy has to move faster.

We partner with venture capital firms and their life sciences portfolio companies to identify and place the executives who can scale innovation, navigate inflection points, and deliver results.

From early-stage builds to growth acceleration, we bring the leadership that drives what’s next.

Explore how we support venture-backed organizations: https://www.slonepartners.com/venture-capital-recruiting/

05/28/2026

We’re excited to share the recent placement of a Corporate Controller for a high-growth organization in the life sciences sector.

This hands-on financial leader will oversee accounting and reporting, strengthen processes and controls, and support continued growth, including M&A integration.

Slone Partners is proud to work with organizations to build leadership teams that drive performance and scale.